Cardiac effects of prostaglandins during global ischemia in isolated perfused cat hearts.
Prostaglandin E1,PGD2, and 16,16 dimethyl prostaglandin E2 were studied in an isolated perfused cat heart preparation during normal conditions and in myocardial ischemia. Under ischemic perfusion, prostaglandin E1 showed some protective action on the release of creatine kinase into perfusate during ischemia, but none of the prostaglandins studied prevented increases in perfusate creatine kinase after reperfusion. Prostaglandin E1 also showed significant membrane stabilizing activity reducing the rate of lysosomal hydrolase release from cat liver lysosomes. Prostaglandin E1 may be beneficial in myocardial ischemia due to its membrane stabilizing action and perhaps to other effects but it did not exert significant protective effects on reperfusion injury of the ischemic myocardium under conditions of these experiments.
D015064:16,16-Dimethylprostaglandin E2 / Q000494:pharmacology; D000527:Alprostadil; D000818:Animals; D002415:Cats; D003327:Coronary Disease / Q000378:metabolism*; D003402:Creatine Kinase / Q000378:metabolism; D006321:Heart / Q000187:drug effects*; D008099:Liver / Q000201:enzymology; D008247:Lysosomes / Q000201:enzymology; D009206:Myocardium / Q000201:enzymology; D010477:Perfusion; D015230:Prostaglandin D2; D011453:Prostaglandins / Q000494:pharmacology*; D011457:Prostaglandins D / Q000494:pharmacology; D011458:Prostaglandins E / Q000494:pharmacology; D013997:Time Factors
D011453:Prostaglandins; D011457:Prostaglandins D; D011458:Prostaglandins E; D003402:Creatine Kinase; D000527:Alprostadil; D015064:16,16-Dimethylprostaglandin E2; D015230:Prostaglandin D2